Key result
Age-specific aldosterone-renin ratio cutoffs optimize primary aldosteronism screening, with ideal cutoffs of 3.7 for patients ≥60 years, 2.0 for 40-59 years, and 1.0 for <40 years.
Why the study?
Does the use of age-stratified aldosterone-renin ratio (ARR) cutoffs improve the diagnostic accuracy for primary aldosteronism screening in hypertensive patients?
Observational (n=485)
Does the use of age-stratified aldosterone-renin ratio (ARR) cutoffs improve the diagnostic accuracy for primary aldosteronism screening in hypertensive patients?
Age-specific cutoffs for the aldosterone-renin ratio are necessary to maintain high diagnostic sensitivity for primary aldosteronism, with lower cutoffs required for younger patients.
Age-specific ARR cutoffs may optimize PA screening sensitivity; leaves open prospective validation before routine adoption.
Aim . This retrospective study is aimed at investigating whether aldosterone-renin ratio (ARR) cutoffs calculated by the plasma aldosterone concentration (PAC)/plasma renin concentration (PRC) should be set differently in patients of different ages. Methods . 521 hypertensive patients were screened for primary aldosteronism (PA) by the PAC/PRC. 174 patients diagnosed with PA and 311 patients with essential hypertension (EH) were included in the final analysis. Subjects were subdivided into four age groups: <40, 40–49, 50–59, and ≥60 years old. Results . The accuracy of the ARR varied greatly among the different age groups. An ARR of 3.7 (ng/dl)/( μ IU/ml) had a sensitivity of 100% and a specificity of 80% in patients ≥ 60 years old. With this cutoff, the sensitivities in patients < 40, 40–49, and 50–59 years old were 74%, 82%, and 87%, respectively, and the specificities were 94%, 95%, and 94%, respectively. To achieve a sensitivity higher than 90%, the ARR cutoff needed to be lowered to 2.0 (ng/dl)/( μ IU/ml) for patients 40–49 and 50–59 years old, resulting in sensitivities of 90% and 95%, respectively, and specificities of 80% and 84%, respectively. To achieve a sensitivity higher than 90%, the ARR cutoff needed to be lowered to 1.0 (ng/dl)/( μ IU/ml) for patients < 40 years old, resulting in a sensitivity of 90% and a specificity of 82%. Conclusions . An ARR of 3.7 (ng/dl)/( μ IU/ml) is optimal for patients ≥ 60 years; for patients 40–59 years, the optimal ARR cutoff is 2.0; for those younger than 40 years, an ARR of 1.0 may be more reasonable.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2018) conducted an observational in Hypertension / Primary Aldosteronism (n=485). Age-specific aldosterone-renin ratio (ARR) cutoffs was evaluated on Sensitivity and specificity of ARR cutoffs for primary aldosteronism. Age-specific aldosterone-renin ratio cutoffs optimize primary aldosteronism screening, with ideal cutoffs of 3.7 for patients ≥60 years, 2.0 for 40-59 years, and 1.0 for <40 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: